BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 32410046)

  • 21. Complete Remission and Long-term Survival of a Patient with a Diffuse Large B-cell Lymphoma Under
    Gutsch J; Werthmann PG; Rosenwald A; Kienle GS
    Anticancer Res; 2018 Sep; 38(9):5363-5369. PubMed ID: 30194190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 3q27 and 18q21 translocations for follicular lymphoma and diffuse large B-cell lymphoma in the rituximab era.
    Watanabe R; Tomita N; Matsumoto C; Hattori Y; Matsuura S; Takasaki H; Hashimoto C; Fujita H; Fujisawa S; Ishigatsubo Y
    J Clin Exp Hematop; 2013; 53(2):107-14. PubMed ID: 23995106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diffuse large B-cell lymphoma developed newly after 9-year remission of a follicular lymphoma].
    Hirano T; Tsuji T; Yamasaki H; Toyozumi Y; Arima N; Tsuda H
    Rinsho Ketsueki; 2016 Feb; 57(2):171-4. PubMed ID: 26935635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Everolimus combined with R-CHOP-21 for new, untreated, diffuse large B-cell lymphoma (NCCTG 1085 [Alliance]): safety and efficacy results of a phase 1 and feasibility trial.
    Johnston PB; LaPlant B; McPhail E; Habermann TM; Inwards DJ; Micallef IN; Colgan JP; Nowakowski GS; Ansell SM; Witzig TE
    Lancet Haematol; 2016 Jul; 3(7):e309-16. PubMed ID: 27374464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3A Comparison between R-THP-COP and R-CHOP Regimens for the Treatment of Diffuse Large B-cell Lymphoma in Old Patients: A Single-institution Analysis.
    Araie H; Sakamaki I; Matsuda Y; Tai K; Ikegaya S; Itoh K; Kishi S; Oiwa K; Okura M; Tasaki T; Hosono N; Ueda T; Yamauchi T
    Intern Med; 2017 Sep; 56(18):2407-2413. PubMed ID: 28824057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of diffuse large B-cell lymphoma transformed from primary duodenal follicular lymphoma.
    Miyata-Takata T; Takata K; Sato Y; Taniguchi K; Takahashi Y; Ohara N; Yoshino T
    Pathol Int; 2014 Oct; 64(10):527-32. PubMed ID: 25186289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary parenchymal CNS involvement by lymphoma including rare types: Follicular and EBV-positive NK/T cell lymphoma, nasal type.
    Kleinschmidt-DeMasters BK; Gilani A
    Ann Diagn Pathol; 2021 Aug; 53():151765. PubMed ID: 34147846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4.
    Walewski J; Paszkiewicz-Kozik E; Michalski W; Rymkiewicz G; Szpila T; Butrym A; Giza A; Zaucha JM; Kalinka-Warzocha E; Wieczorkiewicz A; Zimowska-Curyło D; Knopińska-Posłuszny W; Tyczyńska A; Romejko-Jarosińska J; Dąbrowska-Iwanicka A; Gruszecka B; Jamrozek-Jedlińska M; Borawska A; Hołda W; Porowska A; Romanowicz A; Hellmann A; Stella-Hołowiecka B; Deptała A; Jurczak W
    Br J Haematol; 2020 Mar; 188(6):898-906. PubMed ID: 31792945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bendamustine-rituximab therapy is effective for transformed follicular lymphoma with significant expression of p53].
    Kuroda H; Jomen W; Miura S; Arihara Y; Yamada M; Hirako T; Abe T; Sakurai T; Fujii S; Maeda M; Fujita M; Nagashima K; Okagawa Y; Hoki T; Kato J
    Gan To Kagaku Ryoho; 2013 Aug; 40(8):1055-8. PubMed ID: 23986050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Non-Hodgkin lymphoma of the mandible--a case report with differential diagnostic considerations].
    Heuberger BM; Weiler D; Bussmann C; Kuttenberger JJ
    Schweiz Monatsschr Zahnmed; 2011; 121(5):449-60. PubMed ID: 21656387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Grade 3 Follicular Lymphoma: Outcomes in the Rituximab Era.
    Mustafa Ali M; Rybicki L; Nomani L; Rouphail B; Dean RM; Hill BT; Jagadeesh D; Pohlman B; Hsi ED; Smith MR
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):797-803. PubMed ID: 28789937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant lymphoma of the vagina successfully treated with rituximab, adryamicin, cyclophosphamide, vincristine sulfate, and prednisolone.
    Nasu K; Okamoto M; Nishida M; Takai N; Narahara H
    Eur J Gynaecol Oncol; 2012; 33(2):219-22. PubMed ID: 22611969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
    Belotti A; Doni E; Bolis S; Rossini F; Casaroli I; Pezzatti S; Pogliani EM; Pioltelli PE
    Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):208-13. PubMed ID: 25468321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transformation of jejunoileal follicular lymphoma into diffuse large B-cell lymphoma detected using double-balloon enteroscopy.
    Nishimura T; Kuwai T; Imagawa H; Kohno H
    BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30021733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct Costs Associated with Relapsed Diffuse Large B-Cell Lymphoma Therapies.
    Purdum A; Tieu R; Reddy SR; Broder MS
    Oncologist; 2019 Sep; 24(9):1229-1236. PubMed ID: 30850561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pattern of failure and optimal treatment strategy for primary gastric diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.
    Kang HJ; Lee HH; Jung SE; Park KS; O JH; Jeon YW; Choi BO; Cho SG
    PLoS One; 2020; 15(9):e0238807. PubMed ID: 32960887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testicular diffuse large cell lymphoma with tubule preservation--molecular genetic evidence of transformation from previous follicular lymphoma.
    Lasota J; Nordling S; Miettinen M
    Virchows Arch; 2000 Mar; 436(3):276-83. PubMed ID: 10782887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effective therapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy with obinutuzumab for follicular lymphoma in leukemic phase].
    Osanai S; Oshima S; Itoi S; Kato Y; Ryuzaki M; Izuka Y; Tanaka N; Ishiyama M; Shinohara A; Yoshinaga K; Shiseki M; Onizuka H; Nagashima Y; Tanaka J
    Rinsho Ketsueki; 2023; 64(2):119-124. PubMed ID: 36990731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
    Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic T/histiocyte-rich large B-cell lymphoma: A case report and review of literature.
    Zheng SM; Zhou DJ; Chen YH; Jiang R; Wang YX; Zhang Y; Xue HL; Wang HQ; Mou D; Zeng WZ
    World J Gastroenterol; 2017 Jun; 23(24):4467-4472. PubMed ID: 28706431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.